November 11, 2026

Randomized trial: Autoimmune risk score plus fast-track referral speeds diagnosis

There has been no evidence-based guidance for deciding which patients with a positive antinuclear antibody test — a potential indicator of autoimmune disease — need prompt rheumatology referral.

By Paul Govern